DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment advisor, specializes in managing long/short portfolios of predominantly publicly traded biotechnology …

The majority of the DAFNA Team has worked together for over a decade. We pride ourselves on Steadfast Integrity, Intellectual Excellence, Responsiveness and Reliability, and a Dedication …

The majority of the DAFNA Team has worked together for over a decade. We pride ourselves on Steadfast Integrity, Intellectual Excellence, Responsiveness and Reliability, and a Dedication …

DAFNA Capital Management employs fundamental analysis and event-driven strategies to make long and short investments in publicly traded biotechnology and medical device companies.

Dr. Fariba Ghodsian is the Chief Investment Officer of DAFNA Capital Management. Dr. Ghodsian completed her postdoctoral fellowship in protein modeling at Harvard Medical School.

DAFNA Team. Dr. Nathan Fischel; Dr. Fariba Ghodsian; David Fischel; Daniel Fotinich; Dr. Yuanye (Hammond) Sun; Daphna Fischel; Xun Lin; John Scola; Michelle Belson; …

The majority of the DAFNA Team has worked together for over a decade. We pride ourselves on Steadfast Integrity, Intellectual Excellence, Responsiveness and Reliability, and a Dedication …

DAFNA Capital Management's primary investment focus is on publicly-traded companies developing high-value and novel therapeutics, diagnostics and medical devices. Most …

The majority of the DAFNA Team has worked together for over a decade. We pride ourselves on Steadfast Integrity, Intellectual Excellence, Responsiveness and Reliability, and a Dedication …

Limited Partners of the DAFNA funds include Pension Funds, Fund of Hedge Funds, Family Offices, Investment Professionals, and High Net Worth Individuals. Onshore and Offshore …